Results 111 to 120 of about 189,680 (382)
Biomarkers of lung congestion and injury in acute heart failure
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi+9 more
wiley +1 more source
Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. [PDF]
PurposeDeposition of fibrin in the alveolar space is a hallmark of acute lung injury (ALI). Plasminogen activator inhibitor-1 (PAI-1) is an antifibrinolytic agent that is activated during inflammation. Increased plasma and pulmonary edema fluid levels of
Brady, Sandra+4 more
core +2 more sources
Ventilator associated pneumonia and infection control
Ventilator associated pneumonia (VAP) is the leading cause of morbidity and mortality in intensive care units. The incidence of VAP varies from 7% to 70% in different studies and the mortality rates are 20–75% according to the study population ...
Alp Emine, Voss Andreas
doaj +1 more source
Interrater reliability of surveillance for ventilator-associated events and pneumonia [PDF]
OBJECTIVETo compare interrater reliabilities for ventilator-associated event (VAE) surveillance, traditional ventilator-associated pneumonia (VAP) surveillance, and clinical diagnosis of VAP by intensivists.DESIGNA retrospective study nested within a ...
Anderson, Deverick J+6 more
core +2 more sources
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna+18 more
wiley +1 more source
Background Ventilator-associated pneumonia (VAP) is the commonest hospital-acquired infection (HAI) in intensive care. In Asia, VAP is increasingly caused by resistant gram-negative organisms.
Ana Bonell+10 more
semanticscholar +1 more source
Short report: Hospitalization for new‐onset heart failure in survivors of hospitalized COVID‐19
Abstract Aims Previous studies have reported an incidence of new‐onset heart failure (HF) among COVID‐19 survivors ranging from 0.7 to 8.5 per 100 person‐years, but they relied on administrative data for outcome ascertainment. Given the public health implications, a more accurate characterization of the HF burden post‐COVID‐19 is important. Methods and
Vicente Corrales‐Medina+6 more
wiley +1 more source
Introduction: To decrease the risk of complications from ventilator-associated pneumonia, it is essential to implement preventative measures in all ICU patients.
Hoan Minh Hoang+13 more
doaj +1 more source
Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology
Background Ventilator-associated respiratory infection (VARI) is a significant problem in resource-restricted intensive care units (ICUs), but differences in casemix and etiology means VARI in resource-restricted ICUs may be different from that found in ...
Vu Dinh Phu+29 more
doaj +1 more source
Purpose of review Successful treatment of patients with hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) remains a difficult and complex undertaking.
C. Luyt+3 more
semanticscholar +1 more source